J&J Asks Pa. Court To Keep Risperdal Docs Under Seal

Law360, Philadelphia (December 2, 2013, 5:18 PM EST) -- Johnson & Johnson told a Pennsylvania state judge that counsel for plaintiffs in a slew of product liability suits over the drug Risperdal were improperly seeking to publicly release a series of clinical studies that were kept under seal by a 2011 court order.

The company and its subsidiary Janssen Pharmaceuticals Inc. argued in filing last Tuesday that the documents in question were neither filed with the court nor deemed public records, and thus are exempt from public access.

“These materials are generated for scientists, researchers...
To view the full article, register now.